Prevalence of Amyloid PET Positivity in Dementia SyndromesRik Ossenkoppele, Gaël Chételat, David J. Brooks et al.|JAMA|2015Cited by 668
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Alexander Drzezga, Javier Arbizu et al.|The Lancet Neurology|2020Cited by 535
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s diseaseTammie L.S. Benzinger, John C. Morris, Tyler Blazey et al.|Proceedings of the National Academy of Sciences|2013Cited by 388
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older AdultsRachel F. Buckley, Reisa A. Sperling, Elizabeth C. Mormino et al.|JAMA Neurology|2019Cited by 377
Suspected non-Alzheimer disease pathophysiology — concept and controversyClifford R. Jack, Stephanie J. B. Vos, David S. Knopman et al.|Nature Reviews Neurology|2016Cited by 299